Literature DB >> 19430469

Ube3a is required for experience-dependent maturation of the neocortex.

Koji Yashiro1, Thorfinn T Riday, Kathryn H Condon, Adam C Roberts, Danilo R Bernardo, Rohit Prakash, Richard J Weinberg, Michael D Ehlers, Benjamin D Philpot.   

Abstract

Experience-dependent maturation of neocortical circuits is required for normal sensory and cognitive abilities, which are distorted in neurodevelopmental disorders. We tested whether experience-dependent neocortical modifications require Ube3a, an E3 ubiquitin ligase whose dysregulation has been implicated in autism and Angelman syndrome. Using visual cortex as a model, we found that experience-dependent maturation of excitatory cortical circuits was severely impaired in Angelman syndrome model mice deficient in Ube3a. This developmental defect was associated with profound impairments in neocortical plasticity. Normal plasticity was preserved under conditions of sensory deprivation, but was rapidly lost by sensory experiences. The loss of neocortical plasticity is reversible, as late-onset visual deprivation restored normal synaptic plasticity. Furthermore, Ube3a-deficient mice lacked ocular dominance plasticity in vivo when challenged with monocular deprivation. We conclude that Ube3a is necessary for maintaining plasticity during experience-dependent neocortical development and suggest that the loss of neocortical plasticity contributes to deficits associated with Angelman syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19430469      PMCID: PMC2741303          DOI: 10.1038/nn.2327

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  47 in total

1.  A developmental switch in the signaling cascades for LTP induction.

Authors:  Hiroki Yasuda; Alison L Barth; David Stellwagen; Robert C Malenka
Journal:  Nat Neurosci       Date:  2003-01       Impact factor: 24.884

2.  Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression.

Authors:  Marcie Colledge; Eric M Snyder; Robert A Crozier; Jacquelyn A Soderling; Yetao Jin; Lorene K Langeberg; Hua Lu; Mark F Bear; John D Scott
Journal:  Neuron       Date:  2003-10-30       Impact factor: 17.173

3.  Postnatal neurodevelopmental disorders: meeting at the synapse?

Authors:  Huda Y Zoghbi
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

Review 4.  Critical period plasticity in local cortical circuits.

Authors:  Takao K Hensch
Journal:  Nat Rev Neurosci       Date:  2005-11       Impact factor: 34.870

5.  Effects of visual experience on activity-dependent gene regulation in cortex.

Authors:  Marta Majdan; Carla J Shatz
Journal:  Nat Neurosci       Date:  2006-04-02       Impact factor: 24.884

6.  Visual experience and deprivation bidirectionally modify the composition and function of NMDA receptors in visual cortex.

Authors:  B D Philpot; A K Sekhar; H Z Shouval; M F Bear
Journal:  Neuron       Date:  2001-01       Impact factor: 17.173

7.  Visual deprivation reactivates rapid ocular dominance plasticity in adult visual cortex.

Authors:  Hai-Yan He; William Hodos; Elizabeth M Quinlan
Journal:  J Neurosci       Date:  2006-03-15       Impact factor: 6.167

8.  Persistence of experience-induced homeostatic synaptic plasticity through adulthood in superficial layers of mouse visual cortex.

Authors:  Anubhuthi Goel; Hey-Kyoung Lee
Journal:  J Neurosci       Date:  2007-06-20       Impact factor: 6.167

9.  Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression.

Authors:  R M Mulkey; S Endo; S Shenolikar; R C Malenka
Journal:  Nature       Date:  1994-06-09       Impact factor: 49.962

10.  NeuN, a neuronal specific nuclear protein in vertebrates.

Authors:  R J Mullen; C R Buck; A M Smith
Journal:  Development       Date:  1992-09       Impact factor: 6.868

View more
  160 in total

Review 1.  New views of Arc, a master regulator of synaptic plasticity.

Authors:  Jason D Shepherd; Mark F Bear
Journal:  Nat Neurosci       Date:  2011-01-30       Impact factor: 24.884

2.  Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.

Authors:  Richard M Gustin; Terry Jo Bichell; Michael Bubser; Jennifer Daily; Irina Filonova; Davit Mrelashvili; Ariel Y Deutch; Roger J Colbran; Edwin J Weeber; Kevin F Haas
Journal:  Neurobiol Dis       Date:  2010-04-25       Impact factor: 5.996

Review 3.  Ras and Rap signaling in synaptic plasticity and mental disorders.

Authors:  Ruth L Stornetta; J Julius Zhu
Journal:  Neuroscientist       Date:  2010-04-29       Impact factor: 7.519

Review 4.  Protein degradation and memory formation.

Authors:  Diasynou Fioravante; John H Byrne
Journal:  Brain Res Bull       Date:  2010-11-13       Impact factor: 4.077

Review 5.  Pharmacological therapies for Angelman syndrome.

Authors:  Wen-Hann Tan; Lynne M Bird
Journal:  Wien Med Wochenschr       Date:  2016-01-12

Review 6.  Stem cells and modeling of autism spectrum disorders.

Authors:  Beatriz C G Freitas; Cleber A Trujillo; Cassiano Carromeu; Marianna Yusupova; Roberto H Herai; Alysson R Muotri
Journal:  Exp Neurol       Date:  2012-10-02       Impact factor: 5.330

Review 7.  Activity-dependent neuronal signalling and autism spectrum disorder.

Authors:  Daniel H Ebert; Michael E Greenberg
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

8.  E6AP in the brain: one protein, dual function, multiple diseases.

Authors:  Jimmy El Hokayem; Zafar Nawaz
Journal:  Mol Neurobiol       Date:  2013-10-05       Impact factor: 5.590

9.  NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2.

Authors:  Severine Durand; Annarita Patrizi; Kathleen B Quast; Lea Hachigian; Roman Pavlyuk; Alka Saxena; Piero Carninci; Takao K Hensch; Michela Fagiolini
Journal:  Neuron       Date:  2012-12-20       Impact factor: 17.173

10.  Altered social behavior and neuronal development in mice lacking the Uba6-Use1 ubiquitin transfer system.

Authors:  Peter C W Lee; Jean-Cosme Dodart; Liviu Aron; Lydia W Finley; Roderick T Bronson; Marcia C Haigis; Bruce A Yankner; J Wade Harper
Journal:  Mol Cell       Date:  2013-03-14       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.